Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy

Summary

Study investigators will examine the absorption characteristics of apixaban, a direct-acting oral anticoagulation, in patients who have underwent a particular kind of surgery (pancreaticoduodenectomy) which involves resection of the duodenum.

Timeline

Start

2020-03-03

Primary completion

2020-07-25

Completion

2021-09-01

Drugs

Indications